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INTRODUCTION
Endometriosis is defined as endometrium-like tis-
sue found outside uterus, which causes a chronic
inflammatory reaction. This disease is chronic and
progressive. Physiologically, there is a significant
molecular difference between eutopic endometrial
tissue and endometriosis. The difference is obser-
ved on the evidence of cellular activity of the lesion,
the progressivity, its ability to impair normal physi-
ological process, and also its ability to form a mas-
sive invasive mass.1-3
Endometriosis is a benign disease with high-pro-
liferative property. Proliferation is associated with
the progressivity of the disease, while the progres-
sivity is marked by the ability to form a massive
mass, as discussed here it is the endometriotic cyst,
and to invade the surrounding tissue, represented
by the stage of the disease.
Proliferation is the key marker of tumor pro-
gressivity. One of the biochemical factors to mea-
sure proliferation is Ki-67, being immunohistoche-
mically examined.4-9 Ki-67 is a protein marking cell
proliferation. In interphases the antigen can be de-
tected in the nucleus, just as protein is on the chro-
mosome in mitotic phases. Ki-67 protein appears
in every active phases in cell fission (G1, S, G2, and
mitotic) but is undetected in the resting phase (G0),
making Ki-67 a good marker to determine cellular
growth fraction.4-9
METHOD
This is a cross-sectional observational analytical
study involving 56 patients diagnosed with en-
dometriosis who had had histopathological exami-
nation and laparotomic/laparoscopic cystectomy
or salpingo-oophorectomy procedure in Depart-
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Abstrak
Tujuan: Untuk menganalisis hubungan antara Ki-67 ekspresi dengan
ukuran kista dan tahap endometriosis, dan kekuatan hubungan di an-
tara mereka.
Metode: Penelitian ini merupakan penelitian observasional analitik
dengan metode potong lintang menggunakan 56 parafin blok dari
subyek didiagnosis dengan endometriosis, yang telah menjalani ope-
rasi laparotomi atau laparoskopi. Penelitian ini dilakukan di Rumah
Sakit Hasan Sadikin pada bulan September-November 2012.
Hasil: Menunjukkan hubungan yang signifikan antara Ki-67 bereks-
presi dan ukuran kista endometriosis (p < 0,0001), juga dengan kore-
lasi yang kuat (r = 0,55) sesuai dengan kriteria Guilford. Ada juga
hubungan yang signifikan antara Ki-67 dan ekspresi tahap endome-
triosis (p <0,0001), dengan korelasi yang kuat (r = 0,564) sesuai de-
ngan kriteria Guilford.
Kesimpulan: Ekspresi Ki-67 berkorelasi dengan ukuran kista dan ta-
hap endometriosis.
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ment of Obstetrics and Gynecology of Dr. Hasan
Sadikin Hospital, aged 20-42 years old, with stage
III-IV endometriosis. From the subjects, the expres-
sion Ki-67 protein and endometriotic cyst size
were then measured.
The paraffin blocks of endometriotic cyst ob-
tained from the subjects after laparotomic/laparo-
scopic cystectomy or salpingo-oophorectomy pro-
cedure are examined as histopathologic specimen
and stained with the immunohistochemical Ki-67
dye. Cells expressing Ki-67 would have been dyed
brown, while normal cells would appeared as pale
blue in color. The specimens showing Ki-67 were
then examined under Olympus CX 21 light micro-
scope with 400x magnification, to be counted for
each 100 cells in five high power field, measured
for the Ki-67 expression.
The data were documented and then analyzed
using SPSS version 18.0 for Windows. The categori-
cal data were analyzed with Gamma correlation
test for homogenous data and Somers’d correlation
test for inhomogeneous data. After the hypothesis
testing and significant result achieved, the correla-
tion strength would be determined with Guilford
criteria (1956). P value <0.05 reflects significant re-
sult.
RESULT
The study was conducted from September to No-
vember 2012 with 56 subjects who met the inclu-
sion criteria. Data that were collected included age,
parity, cyst size upon surgery, and endometriosis
stage (stage III-IV). Paraffin blocks of endometrio-
tic cyst were then examined for Ki-67 expression
in the anatomical pathology laboratory of Dr. Ha-
san Sadikin Hospital. Subjects of this study were
not compared with controls, due to the difficulty in
finding samples of normal ovarian tissue.
Table 1. Characteristic of Patients with Endometriotic
Cyst by Age and Parity.
Age (years old) Parity




Table 1 shows the descriptive data of the sub-
jects’ age and parity. Age of the subjects ranged be-
tween 19-49 years old, with mean of 35.50 (± 7.54)
years old. Parity of the subjects ranged between
0-5, with mean of 1.18 (± 1.22).
Table 2. Cyst Size and Ki-67 expression in Endometriotic
Cyst.
Age (years old) Parity
Mean ± SD 8.96 ± 5.68 35.71 ± 30.63
Minimum 27 10
Maximum  2 90
Range 29 80
Table 2 shows the descriptive data of cyst size
and Ki-67 expression. The size of the cysts are 2-29
cm, with mean of 8.96 (± 5.68) cm. while the Ki-67
expression ranges 10-80%, with mean of 35.71 (±
30.63) %.
Table 3 shows a significant correlation between
Ki-67 expression and endometriotic cyst size, with
p value of <0.0001 (p < 0.05), and correlation co-
efficient of 0.55 which reflects strong correlation
according to Guilford criteria.






Cyst Size < 6 cm Cyst Size > 6 cm
Low 14 (50%) 14 (50%) r = 0.550 p < 0.0001*
Moderate  2 (10%) 18 (90%) 
High  0 (0%)  8 (100%)
Note: * Somers’d correlation test for inhomogeneous categorical data; p< 0.05 (significant).
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Table 4 shows a significant association between
Ki-67 expression and endometriosis stage. Statisti-
cal analysis with Somers’d test results in p value of
< 0.0001 (p < 0.05) and correlation coefficient of
0.564, reflecting a significantly strong correlation
based on Guilford criteria.
DISCUSSION
The result of this study shows a significant corre-
lation between Ki-67 expression and endometriotic
cyst size, with p value of <0.0001 (p<0.05), and cor-
relation coefficient of 0.55 which reflects strong
correlation according to Guilford criteria.
No other study had reported the association be-
tween Ki-67 expression and endometriotic cyst
size. However some studies had analyzed the asso-
ciation between Ki-67 and size of other tumor such
as breast tumor.
A prospective study conducted by Johnston, et
al. on breast cancer patients who had chemothe-
rapy and hormonal therapy reported a strong cor-
relation between Ki-67 and breast tumor size. In
the study, Ki-67 was used as the proliferative index
to reflect the therapy efficacy. Low level of Ki-67
reflects a low proliferation rate and tumor regres-
sion after therapy.10-12
The association of Ki-67 and respond to chemo-
therapy is obviously concluded. Five of six studies
have reported that Ki-67 predicts respond to che-
motherapy clinically and histopathologically in pa-
tients with breast cancer. High level of Ki-67 is as-
sociated with good response to therapy, being clini-
cally marked by the diminished size of tumor and
histopathologically by the tumor grading. On the
other hand, high level of Ki-67 which is associated
with good response to therapy, also gives a poor
prognosis. While good response clinically and mo-
reover pathologically reflecting a complete respon-
se, is associated with a better long term prognosis.
This reflects the need of stratification based on the
level of Ki-67 which would improve the prognosis
of clinical response to neoadjuvant chemothera-
py.11-14
The increase of Ki-67 expression in endometrio-
tic cyst shows that endometriosis is highly prolif-
erative. The high proliferation is caused by the en-
dometrial cells outside uterine cavity which trigger
inflammatory reaction, these cells invaginate and
form cystic mass. Chronic and progressive inflam-
mation is able to form invasive mass, such as a ma-
ssive endometriotic cyst in this case.8,15
This study also shows a significant association
between Ki-67 expression and endometriosis sta-
ge. Statistical analysis with Somers’d test results in
p value of <0.0001 (p<0.05) and correlation coef-
ficient of 0.564, reflecting a significantly strong cor-
relation based on Guilford criteria.
The more advanced stage of the endometriosis,
the higher is the Ki-67 expression. This has been
proven by Li, et al.16 The study reported different
expression of Ki-67 in each stages, given only few
of (+3) and (+4) staining in early stage, even really
close to those of the control group. This explains
that in the early stage of proliferation, the infiltra-
tion or invasion are low, consistent with the finding
from surgery that the endometriotic lesions were
superficial with not much of adhesion. The Ki-67
expression was different in the later stage, in which
there were more of (+3) and (+4) staining results.
There is a positive correlation between endome-
triosis stage and Ki-67 expression, this explains the
importance of proliferation in progressivity of the
disease.15,16 In more advanced stage of disease, ac-
cording to AFS score, there would be deeper en-
dometriotic lesions, more adhesion, and oblitera-
tion in cavum douglasi. Consistent with the etiopa-
thogenesis of endometriosis, as endometrial cells
reach the implantation sites outside uterine cavity
by menstrual blood retrograde, lymphogenic, or




Stage III Endometriosis Stage IV Endometriosis
Low 20 (71.4%)  8 (28.6%) r = 0.564 p < 0.0001*
Moderate  6 (30%)  14 (70%)  
High  0 (0%)    8 (100%) 
Note: * Somers’d correlation test for inhomogeneous categorical data; p< 0.05 (significant).
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hematogenic, these cells would adhere and invade
ovary or peritoneal structures. The invasion would
be deeper with adequate vascularization and re-
lease of cytokines.8,15
In advanced stage of endometriosis, prolifera-
tion is enhanced, as seen from the increased ex-
pression of Ki-67. Whenever the cellular prolifera-
tive property is increased, the cell will grow uncon-
trolled like tumor does. These cells will attack the
surrounding structures, causing adhesion which
can lead to organ distortion.1,8,15
Endometriosis has been recognized to be hor-
monal-dependent. It is has some properties of ma-
lignancy, such as the high rate of proliferation,
growth, and invasion, which causes injury of or-
gans, according to the stage of the disease. 1,8,15,17
Nissole, et al. in 1997 reported that Ki-67 de-
pends on the menstrual cycle.18 In normal endo-
metrial cell, the proliferative activity increases in
proliferative phase of the cycle, and declines in the
secretory phase. Endometriotic cell shows similar
activity, in which its proliferation enhances in pro-
liferative phase of the cycle. However, it only shows
a little insignificant decline of the proliferative ac-
tivity in the secretory phase.
Park, et al. in 2008 also reported the similar re-
sult.19 The expression of Ki-67 is associated with
the menstrual cycle, that the endometriotic cells
proliferation is more extensive in the proliferative
phase of menstruation, but with a significantly
lower activity in the secretory phase.
Working on the same topic, Li et al. in 1993 com-
pared the proliferative activity of endometriotic
cells through menstrual cycle. The activity increa-
ses in the end of proliferative phase of menstrual
cycle, in the middle and the end of secretory phase.
Those former studies indicated that the prolif-
erative activity of endometriotic cells depend on
the menstrual cycle. This is consistent with the re-
sult of this study. However, one subject shows a
low Ki-67 expression, while having a large cyst
with advanced stadium. This might be caused by
the subject was in her secretory phase of menstrual
cycle, in which the proliferative activity is lower
than its activity in the proliferative phase.
CONCLUSSION
There is a strong positive correlation between Ki-
67 expression and the size of endometriotic cyst.
There is also a strong positive correlation between
Ki-67 expression and the stage of endometriosis.
SUGGESTIONS
Another study is needed to prove the role of Ki-67
in endometriosis, so that the pathogenesis of en-
dometriosis will be better explained. Ki-67 is used
as an immunohistochemical marker in patients
with endometriosis to predict the severity of the
disease. Further study having Ki-67 to predict re-
currence in patients with high expression of Ki-67
who had undergone cystectomy, is encouraged.
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